1. E. O. Trofimov and N. V. Izvekov, “Analysis of the market of drugs for the treatment of dementia in Russia,” Remedium, 9, 16–25 (2019), https://doi.org/10.21518/1561-5936-2019-9-16-25.
2. E. I. Gusev and A. N. Bogolepova, Cognitive Disorders in Cerebrovascular Diseases, MEDpress-inform, Moscow (2013).
3. A. N. Bogolepova, A. N. Jyravleva, and E. V. Makhnovich, “Prospects for the diagnosis of Alzheimer’s disease using optical coherence tomography,” Ros. Fiziol. Zh., 117, No. 9, 112–117 (2017), https://doi.org/10.17116/jnevro201711791112-117.
4. M. Prince, E. Albanese, M. Guerchet, and M. Prina, World Alzheimer Report 2014: Dementia and Risk Reduction an Analysis of Protective and Modifiable Factors (2014), https://www.alzint.org/u/WorldAlzheimerReport2014.pdf.
5. World Alzheimer Report 2015. The Global Impact of Dementia. An analysis of prevalence, incidence, cost and trends. Published by Alzheimer’s Disease International (ADI), London (2015), https://www.dementiaallianceinternational.org/wp-content/uploads/2015/08/World-Alzheimer-Report-2015-Summary-2015.